Bivalent vaccination of sex reversed hybrid tilapia against Streptococcus iniae and Vibrio vulnificus

Aquaculture

Volumn 354-355, Issue , 2012, Pages 45-49

  Shoemaker, Craig A ^a   LaFrentz, Benjamin R ^a   Klesius, Phillip H ^a  

^a AQUATIC ANIMAL HEALTH RESEARCH UNIT   (United States)

Author keywords

Antibody; Bivalent vaccine; Streptococcus iniae; Tilapia; Vibrio vulnificus

Indexed keywords

ANTIBODY; BACTERIUM; CICHLID; COST-BENEFIT ANALYSIS; DISEASE SEVERITY; FISH CULTURE; HANDLING STRESS; HYBRID; IMMUNITY; SEX REVERSAL; SURVIVAL; VACCINATION; VACCINE;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; OREOCHROMIS; OREOCHROMIS AUREUS; POSIBACTERIA; STREPTOCOCCUS INIAE; TILAPIA; VIBRIO VULNIFICUS;

EID: 84861655676     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquaculture.2012.04.033     Document Type: Article

References (41)

1. Agnew W., Barnes A.C. Streptococcus iniae: an aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Veterinary Microbiology 2007, 122:1-15.
2. Amend D.F. Potency testing of fish vaccines. Developments in Biological Standardization 1981, 49:447-454.
3. Amend D.F., Johnson K.A. Evidence for lack of antigenic competition among various combinations of Vibrio anguillarum, Yersinia ruckeri, Aeromonas salmonicida and Renibacterium salmoninarum bacterins when administered to salmonid fishes. Journal of Fish Diseases 1984, 7:293-299.
4. Austin B. Vibrios as causal agents of zoonoses. Veterinary Microbiology 2010, 140:310-317.
5. Baiano J.C.F., Barnes A.C. Towards control of Streptococcus iniae. Emerging Infectious Diseases 2009, 15:1891-1896.
6. Bastardo A., Ravelo C., Castro N., Calheiros J., Romalde J.L. Effectiveness of bivalent vaccines against Aeromonas hydrophila and Lactococcus garvieae infections in rainbow trout Oncorhynchus mykiss (Walbaum). Fish & Shellfish Immunology 2012, 32:756-761.
7. Bisharat N., Agmon V., Finkelstein R., Raz R., Ben-Dror G., Lerner L., Soboh S., Colodner R., Cameron D.N., Wykstra D.L., Swerdlow D.L., Farmer J.J. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. The Lancet 1999, 354:1421-1424.
8. Chen C.-Y., Chao C.-B., Bowser P.R. Infection of tilapia Oreochromis sp. by Vibrio vulnificus in freshwater and low-salinity environments. Journal of The World Aquaculture Society 2006, 37:82-88.
9. Collado R., Fouz B., Sanjuan E., Amaro C. Effectiveness of different vaccine formulations against vibriosis cause by Vibrio vulnificus serovar E (biotype 2) in European eels Anguilla anguilla. Diseases of Aquatic Organisms 2000, 43:91-101.
10. Eldar A., Horovitcz A., Bercovier H. Development and efficacy of a vaccine against Streptococcus iniae infection in farmed rainbow trout. Veterinary Immunology and Immunopathology 1997, 56:175-183.
11. FAO The State of World Fisheries and Aquaculture 2010 2010, Rome, Italy. 197 pp.
12. Fouz B., Larsen J.L., Amaro C. Vibrio vulnificus serovar A: an emerging pathogen in European anguilliculture. Journal of Fish Diseases 2006, 29:285-291.
13. Hoel K., Salonius K., Lillehaug A. Vibrio antigens of polyvalent vaccines enhance the humoral immune response to Aeromonas salmonicida antigens in Atlantic salmon (Salmo salar L.). Fish & Shellfish Immunology 1997, 7:71-80.
14. Jones M.K., Oliver J.D. Vibrio vulnificus: disease and pathogenesis. Infection and Immunity 2009, 77:1723-1733.
15. Klesius P.H., Shoemaker C.A., Evans J.J. Efficacy of a killed Streptococcus iniae vaccine in tilapia (Oreochromis niloticus). Bulletin European Association of Fish Pathology 1999, 19(1):1-3.
16. Klesius P.H., Shoemaker C.A., Evans J.J. Efficacy of single and combined Streptococcus iniae isolate vaccine administered by intraperitoneal and intramuscular routes in tilapia (Oreochromis niloticus). Aquaculture 2000, 188:237-246.
17. Klesius P.H., Shoemaker C.A., Evans J.J., Lim C. Vaccines: prevention of diseases in aquatic animals. Nutrition and Fish Health 2001, 317-335. The Haworth Press, Inc., Binghamton, New York. C. Lim, C. Webster (Eds.).
18. Klesius P.H., Evans J.J., Shoemaker C.A., Pasnik D.J. A vaccination and challenge model using calcein marked fish. Fish & Shellfish Immunology 2006, 20:20-28.
19. Klesius P.H., Shoemaker C.A., Evans J.J. Streptococcus: a worldwide fish health problem. Proceedings of the 8th International Symposium on Tilapia in Aquaculture 2008, 83-107. Ag. Press Unit, Abbassa, Egypt. H. Elghobashy, K. Fitzsimmons (Eds.).
20. LaFrentz B.R., Shoemaker C.A., Klesius P.H. Immunoproteomic analysis of the antibody response obtained in Nile tilapia following vaccination with a Streptococcus iniae vaccine. Veterinary Microbiology 2011, 152:346-352.
21. Li A., Yang W., Hu J., Wang W., Cai T., Wang J. Optimization by orthogonal array design and humoral immunity of the bivalent vaccine against Aeromonas hydrophila and Vibrio fluvialis infection in crucian carp (Carassius auratus L.). Aquaculture Research 2006, 37:813-820.
22. Mahmud Z.H., Wright A.C., Mandal S.C., Dai J., Jones M.K., Hasan M., Rashid M.H., Islam M.S., Johnson J.A., Gulig P.A., Morris J.G., Ali A. Genetic characterization of Vibrio vulnificus strains from tilapia aquaculture in Bangladesh. Applied and Environmental Microbiology 2010, 76:4890-4895.
23. Martins M.L., Shoemaker C.A., Xu D., Klesius P.H. Effect of parasitism on vaccine efficacy against Streptococcus iniae in Nile tilapia. Aquaculture 2011, 314:18-23.
24. Midtlyng P.J., Reitan L.J., Speilberg L. Experimental studies on the efficacy and side-effects of intraperitoneal vaccination of Atlantic salmon (Salmo salar L.) against furunculosis. Fish & Shellfish Immunology 1996, 6:335-350.
25. Nikoskelainen S., Verho S., Jarvinen S., Madetoja J., Wiklund T., Lilius E.-M. Multiple whole bacterial antigens in polyvalent vaccine may result in inhibition of specific responses in rainbow trout (Oncorhynchus mykiss). Fish & Shellfish Immunology 2007, 22:206-217.
26. Paz S., Bisharat N., Pax E., Kidar O., Cohen D. Climate change and the emergence of Vibrio vulnificus disease in Israel. Environmental Research 2007, 103:390-396.
27. Pylkko P., Lyytikainen T., Ritola O., Pelkonen S., Valtonen E.T. Temperature effect on the immune defense functions of Arctic charr Salvelinus alpinus. Diseases of Aquatic Organisms 2002, 52:47-55.
28. Roberts R.J., Sommerville C. Diseases of tilapias. Manila, Philippines: ICLARM Conference Proceedings 1982, 7:247-263. R.S.V. Pullin, R.H. Lowe-McConnel (Eds.).
29. Sakata T., Hattori M. Characteristics of Vibrio vulnificus isolated from diseased tilapia. Fish Pathology 1988, 23:33-40.
30. Shelby R.A., Klesius P.H., Shoemaker C.A., Evans J.J. Passive immunization of tilapia, Oreochromis niloticus (L.), with anti-Streptococcus iniae whole sera. Journal of Fish Diseases 2002, 25:1-6.
31. Shoemaker C.A., Klesius P.H., Evans J.J. Prevalence of Streptococcus iniae in tilapia, hybrid striped bass and channel catfish from fish farms in the US. American Journal of Veterinary Research 2001, 62:174-177.
32. Shoemaker C.A., Xu D., Evans J.J., Klesius P.H. Parasites and diseases. Tilpaia Biology, Culture and Nutrition 2006, 561-582. Haworth Press, Inc., New York. C. Lim, C.D. Webster (Eds.).
33. ™ technology in Nile tilapia (Oreochromis niloticus). Aquaculture 2006, 255:151-156.
34. Shoemaker C.A., LaFrentz B.R., Klesius P.H., Evans J.J. Protection against heterologous Streptococcus iniae isolates using a modified bacterin vaccine in Nile tilapia Oreochromis niloticus (L.). Journal of Fish Diseases 2010, 33:537-544.
35. Shoemaker C.A., LaFrentz B.R., Klesius P.H. Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus×O. aureus) with an inactivated Vibrio vulnificus vaccine. Biologicals 2011, 39:424-429.
36. Sommerset I., Krossoy B., Biering E., Frost P. Vaccines for fish in aquaculture. Expert Review of Vaccines 2005, 4:89-101.
37. Soto E., Baumgartner W., Wiles J., Hawke J.P. Francisella asiatica as the causative agent of piscine francisellosis in cultured tilapia (Oreochromis sp.) in the USA. Journal of Veterinary Diagnostic Investigation 2011, 23:821-825.
38. Sun Y., Liu C.-S., Sun L. A multivalent killed whole-cell vaccine induces effective protection against Edwardsiella tarda and Vibrio anguillarum. Fish & Shellfish Immunology 2011, 31:595-599.
39. Swain P., Behura A., Dash S., Nayak S.K. Serum antibody response of Indian major carp, Labeo rohita to three species of pathogenic bacteria; Aeromonas hydrophila, Edwardsiella tarda and Pseudomonas fluorescens. Veterinary Immunology and Immunopathology 2007, 117:137-141.
40. Watanabe W.O., Fitzsimmons K., Yi Y. Faming tilapia in saline waters. Tilpaia Biology, Culture and Nutrition 2006, 347-448. Haworth Press, Inc., New York. C. Lim, C.D. Webster (Eds.).
41. Whittington R., Lim C., Klesius P.H. Effect of dietary ß-glucan levels on the growth response and efficacy of Streptococcus iniae vaccine in Nile tilapia, Oreochromis niloticus. Aquaculture 2005, 248:217-225.